Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Lg. Radvanyi"'
Publikováno v:
Cancer Research. 70:P6-08
We recently reported that TRPS-1 (Trichorhinophalangeal Syndrome-1), a new GATA family transcription factor, is a ductal epithelial cell-specific gene expressed in normal breast and over-expressed in the majority of human breast cancer (BC), especial
Publikováno v:
Europe PubMed Central
Apoptosis can be regulated in a number of different systems by the actions of cytokines. Rapamycin has been shown to exert its effects on growth factor-induced cell proliferation, at least in part, by blocking the activation of the p70 S6 kinase and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::28eaa3725025535d9ef60eb559558ca5
http://europepmc.org/abstract/med/7728769
http://europepmc.org/abstract/med/7728769
Autor:
Saberian C; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Amaria RN; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Najjar AM; Department of Pediatrics - Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Radvanyi LG; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ontario Institute for Cancer Research, Ontario, Ontario, Canada., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, USA., Forget MA; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bassett RL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Faria SC; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Glitza IC; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Alvarez E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Parshottam S; Department of Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Prieto V; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lizée G; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wong MK; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McQuade JL; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Diab A; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yee C; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi HA; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel S; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies MA; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hwu P; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA cbernatchez@mdanderson.org Patrick.Hwu@moffitt.org., Bernatchez C; Melanoma Medical Onoclogy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA cbernatchez@mdanderson.org Patrick.Hwu@moffitt.org.; Department of Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 May; Vol. 9 (5).
Autor:
Kozlowski HN; Biomedical Engineering, University of Toronto, Toronto, ON, Canada.; MD/PhD Program, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Farkouh ME; Peter Munk Cardiac Centre, Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, ON, Canada., Irwin MS; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Radvanyi LG; Ontario Institute for Cancer Research, Toronto, ON, Canada., Schimmer AD; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Tabori U; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Rosenblum ND; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2020 Nov 06; Vol. 12 (11), pp. e13278. Date of Electronic Publication: 2020 Oct 19.
Autor:
Tavera RJ; Departments of Melanoma Medical Oncology., Forget MA; Departments of Melanoma Medical Oncology., Kim YU; Departments of Melanoma Medical Oncology., Sakellariou-Thompson D; Departments of Melanoma Medical Oncology., Creasy CA; Departments of Melanoma Medical Oncology., Bhatta A; Departments of Melanoma Medical Oncology., Fulbright OJ; Departments of Melanoma Medical Oncology., Ramachandran R; Departments of Melanoma Medical Oncology., Thorsen ST; Departments of Melanoma Medical Oncology., Flores E; Departments of Melanoma Medical Oncology., Wahl A; Departments of Melanoma Medical Oncology., Gonzalez AM; Departments of Melanoma Medical Oncology., Toth C; Departments of Melanoma Medical Oncology., Wardell S; Departments of Melanoma Medical Oncology., Mansaray R; Departments of Melanoma Medical Oncology., Radvanyi LG; Departments of Melanoma Medical Oncology., Gombos DS; Head and Neck Surgery, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX., Patel SP; Departments of Melanoma Medical Oncology., Hwu P; Departments of Melanoma Medical Oncology., Amaria RN; Departments of Melanoma Medical Oncology., Bernatchez C; Departments of Melanoma Medical Oncology., Haymaker C; Departments of Melanoma Medical Oncology.
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2018 Nov/Dec; Vol. 41 (9), pp. 399-405.
Autor:
Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Hess KR; Department of Biostatistics, The University of Texas MDACC, Houston, Texas., Meng YJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Creasy C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Karpinets T; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas., Fulbright OJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas., Woodman SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Kim YU; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Sakellariou-Thompson D; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Bhatta A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Wahl A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Flores E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Thorsen ST; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Tavera RJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Ramachandran R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Gonzalez AM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Toth CL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Wardell S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Mansaray R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Patel V; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Carpio DJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Vaughn C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Farinas CM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Velasquez PG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Cain S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Ross MI; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Lee JE; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Gershenwald JE; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Lucci A; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Royal R; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Cormier JN; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Wargo JA; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas., Radvanyi LG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Torres-Cabala CA; Department of Pathology, The University of Texas MDACC, Houston, Texas., Beroukhim R; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas. cbernatchez@mdanderson.org rnamaria@mdanderson.org., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas. cbernatchez@mdanderson.org rnamaria@mdanderson.org.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Sep 15; Vol. 24 (18), pp. 4416-4428. Date of Electronic Publication: 2018 May 30.
Autor:
Radvanyi LG; Ontario Institute for Cancer Research, Toronto, Ontario, Canada. laszlo.radvanyi@oicr.on.ca.
Publikováno v:
Nature medicine [Nat Med] 2018 Jun; Vol. 24 (6), pp. 703-704.
Autor:
Ritthipichai K; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas., Haymaker CL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Martinez M; Department of Chemical and Biomolecular Engineering, Cullen College of Engineering, University of Houston, Texas., Aschenbrenner A; Graduate Program in Biostatistics, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas., Yi X; Immunology Platform, Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kale C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vence LM; Immunology Platform, Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas., Hailemichael Y; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Overwijk WW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas., Varadarajan N; Department of Chemical and Biomolecular Engineering, Cullen College of Engineering, University of Houston, Texas., Nurieva R; Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Radvanyi LG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. cbernatchez@mdanderson.org.; Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Oct 15; Vol. 23 (20), pp. 6151-6164. Date of Electronic Publication: 2017 Jul 28.
Autor:
An X; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America., Sendra VG; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America., Liadi I; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America., Ramesh B; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America., Romain G; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America., Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Martinez-Paniagua M; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America., Lu Y; Department of Electrical and Computer Engineering, University of Houston, Houston, Texas, United States of America., Radvanyi LG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Roysam B; Department of Electrical and Computer Engineering, University of Houston, Houston, Texas, United States of America., Varadarajan N; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, United States of America.
Publikováno v:
PloS one [PLoS One] 2017 Aug 24; Vol. 12 (8), pp. e0181904. Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).
Autor:
Lee YH; Department of Immunology., Martin-Orozco N; Department of Immunology.; EMD Serono Research and Development Institute, Inc. 45A Middlesex Turnpike, Billerica, MA 01821, USA., Zheng P; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX 77030, USA.; Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.; The Second Xiangya Hospital, Central South University, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, 139 Renmin Road, Changsha, Hunan 410011, China., Li J; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China., Zhang P; Center for Cancer and Immunology Research, Children's National Health System, Washington DC, 20010 USA., Tan H; Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, 100029, China., Park HJ; Department of Molecular and Cellular Biology., Jeong M; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Chang SH; Department of Immunology., Kim BS; Department of Immunology., Xiong W; Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.; The Second Xiangya Hospital, Central South University, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, 139 Renmin Road, Changsha, Hunan 410011, China., Zang W; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China., Guo L; X-KANG United Biopharmaceutical Science &Technology Co. Ltd., Suzhou, Jiangsu 215000, China., Liu Y; Center for Cancer and Immunology Research, Children's National Health System, Washington DC, 20010 USA., Dong ZJ; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China., Overwijk WW; Department of Melanoma., Hwu P; Department of Melanoma., Yi Q; Departments of Lymphoma and Myeloma, U.T. MD Anderson Cancer Center, 7455 Fannin St., Houston, TX 77054, USA.; Department of Cancer Biology Betsy B. DeWindt Endowed Chair for Cancer Research, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA., Kwak L; Departments of Lymphoma and Myeloma, U.T. MD Anderson Cancer Center, 7455 Fannin St., Houston, TX 77054, USA.; City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA, 91010, USA., Yang Z; Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, 100029, China., Mak TW; The Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON M5G 2M9, Canada., Li W; Department of Molecular and Cellular Biology., Radvanyi LG; Department of Melanoma.; EMD Serono Research and Development Institute, Inc. 45A Middlesex Turnpike, Billerica, MA 01821, USA., Ni L; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China., Liu D; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX 77030, USA.; Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA., Dong C; Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China.
Publikováno v:
Cell research [Cell Res] 2017 Aug; Vol. 27 (8), pp. 1034-1045. Date of Electronic Publication: 2017 Jul 07.